Cambridge Investment Research Advisors, Inc. Teva Pharmaceutical Industries LTD Transaction History

Cambridge Investment Research Advisors, Inc.

  • $29.4 Billion
  • Q3 2024

A detailed history of Cambridge Investment Research Advisors, Inc. transactions in Teva Pharmaceutical Industries LTD stock. As of the latest transaction made, Cambridge Investment Research Advisors, Inc. holds 53,536 shares of TEVA stock, worth $936,880. This represents 0.0% of its overall portfolio holdings.

Number of Shares
53,536
Previous 53,256 0.53%
Holding current value
$936,880
Previous $865,000 11.56%
% of portfolio
0.0%
Previous 0.0%

Shares

31 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 28, 2024
BUY
$15.81 - $18.96 $4,426 - $5,308
280 Added 0.53%
53,536 $965,000
Q2 2024

Jul 26, 2024
BUY
$12.78 - $17.4 $84,360 - $114,857
6,601 Added 14.15%
53,256 $865,000
Q1 2024

Apr 24, 2024
BUY
$10.67 - $14.43 $77,272 - $104,502
7,242 Added 18.37%
46,655 $658,000
Q4 2023

Feb 09, 2024
SELL
$8.12 - $10.63 $28,436 - $37,226
-3,502 Reduced 8.16%
39,413 $411,000
Q3 2023

Oct 24, 2023
BUY
$7.48 - $10.7 $7,001 - $10,015
936 Added 2.23%
42,915 $438,000
Q2 2023

Jul 13, 2023
SELL
$7.2 - $9.47 $72,604 - $95,495
-10,084 Reduced 19.37%
41,979 $316,000
Q1 2023

May 11, 2023
SELL
$8.36 - $11.37 $11,737 - $15,963
-1,404 Reduced 2.63%
52,063 $461,000
Q4 2022

Feb 08, 2023
BUY
$7.95 - $9.48 $39,424 - $47,011
4,959 Added 10.22%
53,467 $488,000
Q3 2022

Oct 17, 2022
BUY
$6.86 - $11.95 $3,498 - $6,094
510 Added 1.06%
48,508 $391,000
Q2 2022

Jul 13, 2022
BUY
$7.38 - $10.4 $7,306 - $10,296
990 Added 2.11%
47,998 $360,000
Q1 2022

May 12, 2022
SELL
$7.33 - $9.39 $45,614 - $58,433
-6,223 Reduced 11.69%
47,008 $441,000
Q4 2021

Feb 03, 2022
SELL
$7.9 - $10.19 $31,686 - $40,872
-4,011 Reduced 7.01%
53,231 $426,000
Q3 2021

Nov 02, 2021
BUY
$8.38 - $10.18 $123,462 - $149,981
14,733 Added 34.66%
57,242 $557,000
Q2 2021

Aug 10, 2021
SELL
$9.9 - $11.56 $68,448 - $79,925
-6,914 Reduced 13.99%
42,509 $420,000
Q1 2021

May 07, 2021
BUY
$10.34 - $12.81 $26,398 - $32,703
2,553 Added 5.45%
49,423 $570,000
Q4 2020

Feb 04, 2021
SELL
$8.61 - $11.04 $63,025 - $80,812
-7,320 Reduced 13.51%
46,870 $452,000
Q3 2020

Oct 29, 2020
SELL
$8.57 - $12.69 $1.02 Million - $1.51 Million
-118,702 Reduced 68.66%
54,190 $488,000
Q2 2020

Jul 27, 2020
SELL
$8.12 - $13.12 $1.07 Million - $1.73 Million
-131,930 Reduced 43.28%
172,892 $2.13 Million
Q1 2020

May 08, 2020
BUY
$6.69 - $13.45 $974,619 - $1.96 Million
145,683 Added 91.54%
304,822 $2.74 Million
Q4 2019

Feb 04, 2020
BUY
$6.53 - $10.72 $830,909 - $1.36 Million
127,245 Added 398.96%
159,139 $1.56 Million
Q3 2019

Nov 06, 2019
BUY
$6.16 - $9.6 $2,383 - $3,715
387 Added 1.23%
31,894 $219,000
Q3 2019

Oct 28, 2019
BUY
$6.16 - $9.6 $585 - $912
95 Added 0.3%
31,507 $216,000
Q2 2019

Aug 15, 2019
SELL
$8.12 - $15.72 $8,647 - $16,741
-1,065 Reduced 3.28%
31,412 $0
Q1 2019

May 08, 2019
BUY
$15.58 - $20.01 $76,513 - $98,269
4,911 Added 17.82%
32,477 $0
Q4 2018

Feb 05, 2019
SELL
$14.59 - $23.84 $31,383 - $51,279
-2,151 Reduced 7.24%
27,566 $425,000
Q3 2018

Nov 02, 2018
SELL
$21.06 - $25.65 $114,587 - $139,561
-5,441 Reduced 15.48%
29,717 $0
Q2 2018

Aug 10, 2018
SELL
$16.77 - $24.71 $50,528 - $74,451
-3,013 Reduced 7.89%
35,158 $0
Q1 2018

May 09, 2018
SELL
$16.68 - $22.07 $130,304 - $172,410
-7,812 Reduced 16.99%
38,171 $0
Q4 2017

Feb 22, 2018
BUY
$11.23 - $19.1 $74,589 - $126,862
6,642 Added 16.88%
45,983 $0
Q3 2017

Nov 07, 2017
BUY
$15.41 - $32.17 $48,310 - $100,852
3,135 Added 8.66%
39,341 $692,000
Q2 2017

Aug 08, 2017
BUY
N/A
36,206
36,206 $1.2 Million

Others Institutions Holding TEVA

# of Institutions
617
Shares Held
563M
Call Options Held
25.2M
Put Options Held
5.08M
View Full List

About TEVA PHARMACEUTICAL INDUSTRIES LTD

TEVA Quotes by TradingView
  • Ticker TEVA
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 1,110,560,000
  • Market Cap $19.4B
  • Description
  • Teva Pharmaceutical Industries Limited, a pharmaceutical company, develops, manufactures, markets, and distributes generic medicines, specialty medicines, and biopharmaceutical products in North America, Europe, and internationally. The company offers sterile products, hormones, high-potency drugs, and cytotoxic substances in various dosage form...
More about TEVA
Track This Portfolio

Track Cambridge Investment Research Advisors, Inc. Portfolio

Follow Cambridge Investment Research Advisors, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Cambridge Investment Research Advisors, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Cambridge Investment Research Advisors, Inc. with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email